Magazine article Drug Topics

Counseling for Bed-Wetting: New Business Opportunity

Magazine article Drug Topics

Counseling for Bed-Wetting: New Business Opportunity

Article excerpt

As Quentin Srnka sees it, there is "more potential for more pharmacists to quickly be compensated for bed-wetting than for diabetes, than for asthma, than for high blood pressure, or hyperlipidemia."

Srnka, Pharm.D., M.B.A., an associate professor at the University of Tennessee, Memphis, was speaking at an educational symposium on "Business Opportunities in Pharmaceutical Care-Focus on Bed-wetting," which took place during the American Pharmaceutical Association's 143rd annual meeting in Nashville in March. The bed-wetting symposium was sponsored by RhonePoulenc Rorer.

Srnka estimated that about 10% of all parents and grandparents who come in to a pharmacy have a child or grandchild who wets the bed. "There is nobody out there in the bed-wetting business," he told the group. And, in his opinion, this area is replete with opportunities.

Bed-wetting, or primary nocturnal enuresis, affects an estimated 5 million to 7 million American children, most of whom are boys. The condition has a strong hereditary component, and scientists recently discovered the approximate location of a gene that may be linked to primary enuresis. Organic causes of nocturnal enuresis can include constipation, diabetes, urinary tract infection, and vaginitis, among others. However, in 97% of cases, no organic cause can be determined.

When working with children who wet the bed, pharmacists should "get a complete history and make sure that someone has provided a good physical exam," said Robert A. Mangione, R.Ph., P.D.Ed., assistant dean-pharmacy student affairs and clinical professor of pharmacy, St. John's University, Jamaica, N.Y. This is especially important "when enuresis is brought to our attention in a community setting," he added.

While the causes of primary nocturnal enuresis are complex and still not completely understood, researchers have learned that some children with this condition have altered nighttime secretions of antidiuretic hormone. Also known as vasopressin, ADH is a pituitary hormone that regulates urinary output.

If it is left untreated, primary nocturnal enuresis will resolve in 15% of children per year, but by 15 years of age, 1% to 2% of adolescents still remain enuretic, Mangione said.

Pharmacists interested in this niche market will want to learn about nonpharmacological strategies for the management of bed-wetting. These include bladder retention training, behavior modification, and motivational techniques.

Pharmacists should also become familiar with enuresis alarms. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.